Comparing two methods of draining fluid from the chest after lung surgery
A Randomized Controlled Study Comparing Valve-regulated Pleural Drainage System to Traditional Closed Chest Tube Drainage
NA · Peking Union Medical College Hospital · NCT06410716
This study is testing if a new way to drain fluid from the chest after lung surgery works better and is safer for lung cancer patients than the traditional method.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Peking Union Medical College Hospital (other) |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06410716 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness of a dry valve-regulated pleural drainage system against traditional water-sealed drainage systems following thoracic surgery for lung cancer patients. The research focuses on evaluating the safety, ease of use, and overall clinical outcomes associated with each drainage method. By conducting a randomized controlled trial, the investigators seek to provide evidence-based recommendations for optimal thoracic drainage practices. The study addresses the limitations of traditional methods, which require constant monitoring and carry risks of complications.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have undergone thoracoscopic lobectomy and lymph node dissection.
Not a fit: Patients who are pregnant, lactating, or have significant organ dysfunction or preoperative pleural effusion or pneumothorax may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved postoperative care and outcomes for lung cancer patients undergoing thoracic surgery.
How similar studies have performed: Preliminary studies have shown advantages of dry valve-regulated drainage systems, suggesting potential success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients who accepted thoracoscopic lobectomy and lymph node dissection; 2. Written consent is able to obtained. Exclusion Criteria: 1. Pregnant or lactating women; 2. Patients with significant dysfunction of organs such as the heart, liver, or kidneys; 3. Patients with pleural effusion or pneumothorax preoperatively.
Where this trial is running
Beijing, Beijing Municipality
- Peking Union Medical College Hospital — Beijing, Beijing Municipality, China (RECRUITING)
Study contacts
- Study coordinator: Lei Liu, MD
- Email: liulei12130@pumch.cn
- Phone: 18105369996
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lung Cancer, lung cancer, thoracic drainage system